LogicBio Therapeutics' Series B Round

LogicBio Therapeutics raised a round of funding on June 28, 2017.

LogicBio Therapeutics is focused on gene therapy, targeting "lifelong cures" for serious, early-onset rare diseases by combining the best of gene therapy and gene editing in a one-time treatment.…

Articles about LogicBio Therapeutics' Series B Round: